NT-proBNP may be used as a risk factor of stroke after the elimination of atrial fibrillation by catheter ablation
30 August 2025 (12:15 - 13:00)
Organised by: 
About the speaker
Kansai Rosai Hospital, Amagasaki (Japan)
7 More presentations in this session
Associate Professor Z. Hijazi (Uppsala, SE)
Selecting patients for targeted therapy with early rhythm control using BMP10 blood biomarker levels
Mr C. Al-Taie (Hamburg, DE)
Doctor A. Jackson (Orebro, SE)
Access the full session
The Event
ESC Congress 2025
30 August 2025
12:15 CET
You may be interested in
Congress Presentation
Congress Session
